This inventor holds 1 USPTO granted patent. Top assignee: Asterand UK Acquisition Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Gordon S Baxter: Innovator in Headache Treatment
Introduction
Gordon S Baxter is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of medicine, particularly in the treatment of primary headache disorders such as migraines. His innovative approach focuses on the use of antagonists of the EPreceptor for prostaglandin E2.
Latest Patents
Gordon S Baxter holds a patent for a method of identifying an inhibitor of the prostanoid EP4 receptor. This invention provides a novel treatment option for primary headache disorders, especially migraines, by utilizing specific antagonists. The patent highlights the use of azole compounds of formula (I) as effective EPreceptor antagonists.
Career Highlights
Baxter is associated with Asterand UK Acquisition Limited, where he continues to advance research in his field. His work has been instrumental in developing new therapeutic strategies for headache management.
Collaborations
Throughout his career, Baxter has collaborated with esteemed colleagues, including Robert Alexander Coleman and Nicholas Tilford. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Gordon S Baxter's contributions to the field of headache treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile